Recommendation 5

The MoD failed to consider the needs of its medical operations in outsourcing commodity procurement to Team Leidos and this has created significant risks for front-line personnel. Since the LCST contract began, the inventory needs of front-line medical personnel have not been well served. In particular, units have faced poor availability of medical inventory and been supplied with items without sufficient shelf life for longer deployments. In 2022, the Royal Navy assessed that, if unresolved, the situation would present a significant risk to life for its personnel. This issue arose because the contract applied a general target across all commodity supply. This meant that lower performance in supplying medical inventory (which generally requires higher performance than other commodities) was masked by better performance elsewhere. Furthermore, there is granularity within what is needed for certain elements of medical inventory: the MoD cited 90%, 95% and 98% inventory level requirements for different medical equipment.4 For the average inventory of “fast-moving commodity type medical items”, the MoD told us that Team Leidos was now achieving the 92% level “on a regular basis”.5 From 2019, the MoD changed the incentivisation in the contract to hit time targets and deliver new projects and equipment faster, which improved the situation but still not to the required level. However, in 2023 because performance for medical had still not improved to the required level, the MoD approved further improvement initiatives which will ultimately require it to pay the supplier a further £13.2 million.6 Recommendation: In its Treasury Minute response, the MoD should write to us setting out how it will ensure that the requirements of medical personnel will be properly addressed in its future inventory management arrangements, and how it will resolve risks more quickly in future. This should include providing data on a quarterly or monthly basis of how performance in the supply of me